Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2 × Hypogonadism × Testosterone × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Neoplasms 4 Hypogonadism 2 Testicular Neoplasms 1 Sexuality 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Fatigue 1 Eunuchism 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Testosterone 2 testosterone undecanoate 1 Gels 1 Drug Evaluation 1 Clomiphene 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04301765 2025-03-11

TEMEC

Seattle Institute for Biomedical and Clinical Research

Phase 2 Recruiting

Eunuchism, Fatigue, Hypogonadism, Neoplasms

NCT04492553 2022-11-29

Vitality

Herlev Hospital

Phase 2 Completed

Hypogonadism, Lymphoma, Neoplasms, Lymphoma, Large B-Cell, Diffuse, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon ⚡